Jonathan Gerber, MD of Levine Cancer Institute discusses a novel approach from a translational research project in identifying stem cell populations in ALL at the 58th ASH Annual Meeting in San Diego, CA.
Jonathan Gerber, MD of Levine Cancer Institute discusses a novel approach from a translational research project in identifying stem cell populations in ALL at the 58th ASH Annual Meeting in San Diego, CA.